Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

500 cancer patients join DNA tracking study to unlock treatment clues

NCT ID NCT06207032

Knowledge-focused Sponsor: Tempus AI Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study enrolls 500 adults with cancer to collect blood and tissue samples over time. Researchers will analyze ctDNA (bits of tumor DNA in the blood) to see how it changes with standard treatment. The goal is to find biomarkers that could predict outcomes and guide future cancer care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors better predict how cancer will respond to treatment and guide more personalized care.
What could go wrong
This is an observational study, not a treatment trial. It collects data only, so it won't directly help participants. Results may take years to influence practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2024

Expected to finish

Jun 2029

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Participants diagnosed with cancer willing to have additional blood samples collected for ctDNA research.

Ages

18 to 99 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. ≥18 years of age 2. Willing to participate in the research 3. Able to provide informed consent 4. Must be diagnosed with cancer Exclusion Criteria: 1\. Not willing or able to have additional blood samples collected

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    25 sites in 2 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Alabama Oncology

    RECRUITING

    Birmingham, Alabama, 35233, United States

  • Aultman Medical Group

    RECRUITING

    Canton, Ohio, 44710, United States

  • Cancer Care Associates of York

    RECRUITING

    York, Pennsylvania, 17403, United States

  • Cancer Care Northwest

    RECRUITING

    Spokane, Washington, 99216, United States

  • Cancer Care Specialists - Reno

    RECRUITING

    Reno, Nevada, 89511, United States

  • Cancer Care Specialists of Illinois

    RECRUITING

    O'Fallon, Illinois, 62269, United States

  • Cancer Specialists of North Florida

    RECRUITING

    Jacksonville, Florida, 32256, United States

  • Cayuga Medical Center

    RECRUITING

    Ithaca, New York, 14850, United States

  • Eastern CT and Hematology and Oncology Associates

    RECRUITING

    Norwich, Connecticut, 06360, United States

  • Fort Wayne

    TERMINATED

    Fort Wayne, Indiana, 46804, United States

  • Frederick Health Regional System

    RECRUITING

    Frederick, Maryland, 21702, United States

  • Goshen Center for Cancer Care

    RECRUITING

    Goshen, Indiana, 46526, United States

  • Hannibal Regional Healthcare System, Inc.

    RECRUITING

    Hannibal, Missouri, 63401, United States

  • Hematology Oncology Associates of Central NY

    RECRUITING

    East Syracuse, New York, 13057, United States

  • Hope Cancer Care of Nevada

    TERMINATED

    Las Vegas, Nevada, 89103, United States

  • Hope and Healing Cancer Services

    RECRUITING

    Hinsdale, Illinois, 60521, United States

  • Illinois Cancer Care

    RECRUITING

    Peoria, Illinois, 61615, United States

  • Lake Regional Health

    RECRUITING

    Osage Beach, Missouri, 65065, United States

  • Morehouse

    RECRUITING

    Atlanta, Georgia, 30310, United States

  • Mosaic Life Care

    ACTIVE_NOT_RECRUITING

    Saint Joseph, Missouri, 64506, United States

  • New Jersey Cancer Center

    TERMINATED

    Belleville, New Jersey, 07109, United States

  • Northwest Oncology and Hematology

    TERMINATED

    Rolling Meadows, Illinois, 60008, United States

  • Oncology Hematology Associates

    RECRUITING

    Springfield, Missouri, 65807, United States

  • PIH Health Whittier Hospital & PIH Health Physicians

    RECRUITING

    Whittier, California, 90605, United States

  • Pan American Center for Oncology Trials

    RECRUITING

    Rio Piedras, Puerto Rico, 00935, Puerto Rico

  • Piedmont Healthcare

    RECRUITING

    Atlanta, Georgia, 30318, United States

  • Regional Cancer Care Associates

    TERMINATED

    Belleville, New Jersey, 07109, United States

  • Sanford Roger Maris Cancer Center (Fargo)

    RECRUITING

    Fargo, North Dakota, 58102, United States

  • Southcoast Centers for Cancer Care

    RECRUITING

    Fairhaven, Massachusetts, 02719, United States

  • Southern Illinois Healthcare

    RECRUITING

    Carterville, Illinois, 62918, United States

  • St. Claire Healthcare

    TERMINATED

    Morehead, Kentucky, 40351, United States

  • Taylor Cancer Research Center

    RECRUITING

    Maumee, Ohio, 43537, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.